Subscribe To
Bavarian nordic to discontinue rsv vaccine programme
Denmark-based Bavarian Nordic said on Saturday it was discontinuing its respiratory syncytial virus (RSV) vaccine programme as its ...
July 22, 2023, 1:22 pm
Our top 10 picks for dividend growth stocks - july 2023
This monthly series of articles focuses on DGI stocks that are likely to provide a high rate of dividend growth rather than a high current yield. We u...
July 22, 2023, 9:00 am
Audusd weekly analysis – july 22, 2023
AUDUSD has been caught in a sideways consolidation phase, trading within a defined range between 0.6170 and 0.7157. Market analysts and traders are cl...
July 22, 2023, 2:34 am
Archer aviation: the best risk/reward in the evtol industry
Archer Aviation Inc., an eVTOL manufacturer, plans to achieve FAA approval for its 'Midnight' aircraft by late 2024, with operations starting in 2025....
July 21, 2023, 2:32 pm
Vir biotechnology (vir) down on influenza study failure
Vir Biotechnology (VIR) crashes after the phase II study evaluating VIR-2482 for preventing symptomatic...
July 21, 2023, 1:42 pm
Wti oil technical: potential bullish reversal “descending wedge” in play
Major downtrend phase from the 7 March 2022 swing high has evolved into a potential bullish reversal �...
July 21, 2023, 8:08 am
Wti oil technical: potential bullish reversal “descending wedge” in play
Major downtrend phase from the 7 March 2022 swing high has evolved into a potential bullish reversal �...
July 21, 2023, 7:49 am
Enphase energy (enph) makes rapid expansion across europe
Enphase Energy (ENPH), with the consistent supply expansions of IQ Batteries and microinverters, contin...
July 21, 2023, 7:42 am
Curium announces publication of [18f]dcfpyl versus [18f]fluoromethylcholine results from european phase iii study (python trial)
PARIS, July 21, 2023 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced today the publication of the results of its European, ...
July 21, 2023, 7:30 am
Cava group: striking a balance between high valuation and promising growth prospects
CAVA's incredible post-IPO rally has put its valuation well above peers. Although CAVA isn't generating revenues comparable to Chipotle yet, I believe...
July 20, 2023, 10:30 pm
Mark e. miller joins nanophase board of directors
ROMEOVILLE, Ill., July 20, 2023 (GLOBE NEWSWIRE) — Nanophase Technologies Corporation (OTCQB: NANX), ...
July 20, 2023, 8:44 pm
: vir biotechnology’s stock slides 40% after it says mid-stage trial of a flu treatment failed to meet main goals
Vir Biotechnology Inc. VIR said Thursday a mid-stage trial of a treatment for symptomatic flu failed to meet its main goals, sending the stock down 40...
July 20, 2023, 5:59 pm
Cruise starts initial robotaxi testing in miami
Cruise, the self-driving arm of General Motors, has begun initial testing and data collection in Miami, the company said in a tweet Wednesday. “
July 20, 2023, 5:48 pm
Broadcom: short-term pain, long-term gem
In my view, AVGO is at least fairly valued right now, which makes it an ideal GARP stock to buy for the long term. However, it is possible that we are...
July 20, 2023, 2:39 pm
Terns pharmaceuticals: facing impressive competition, but not completely out of its depth
TERN's TERN-701 is being developed for Chronic Myeloid Leukemia (CML), but NVS' Scemblix is similar and already approved. TERN-701 may offer benefits ...
July 20, 2023, 1:11 pm
Recludix pharma enters into a strategic collaboration with sanofi to advance novel oral stat6 inhibitor in multiple immunological and inflammatory indications
– Recludix to receive $125 million in near-term payments and potentially more than $1.2 billion subject to future milestones, and up to double-digit...
July 20, 2023, 12:00 pm
Netflix: a new business phase begins
Shares of Netflix Inc. ( NFLX , Financial) tanked 6% in after-hours trading on July 19 after reporting second-quarter earnings....
July 20, 2023, 11:44 am
Why shares of vir biotechnology are plunging thursday
Vir Biotechnology has seen declining revenue because sales of its one marketed product, Sotrovimab, are declining. A ...
July 20, 2023, 11:31 am
Teva pharmaceutical's remarkable growth in 2023: a success story
On August 2, 2023, Teva Pharmaceutical, one of the world's top generic drug manufacturers, will publish its financial report for the second quarter of...
July 20, 2023, 10:43 am
Atossa therapeutics gets green light to open enrollment for phase 2 breast cancer trial in canada
Atossa Therapeutics Inc (NASDAQ:ATOS) has received what's known as a no objection letter from Health Canada in response to its clinical trial applicat...
July 20, 2023, 10:28 am